Compare Moderna, Inc. (MRNA) vs VNET Group Inc (VNET) Price & Performance

Moderna, Inc.Trade

VNET Group IncTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs VNET Group Inc — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while VNET Group Inc trades at $7.7 (market cap $2.19B). The key difference: Moderna, Inc. is far larger — about 10.8× VNET Group Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, VNET Group Inc nearer its low. Which is the better fit depends on your goals.

	MRNA	VNET
Market Cap	$23.60B	$2.19B
Sector	Health	Technology
52-Week High	$81.80	$14.03
52-Week Low	$22.36	$7.34
Enterprise Value	$19.70B	$5.32B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 13 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

VNET

VNET Group rated buy on strong data center growth and rising earnings potential.Seeking Alpha · 4 days agoBullish View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About VNET Group Inc

VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.